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Abstract
Background: Typhoid fever remains a significant health problem in many developing countries. A rapid test with a
performance comparable to that of blood culture would be highly useful. A rapid diagnostic test for typhoid fever,
Tubex®, is commercially available that uses particle separation to detect immunoglobulin M directed towards
Salmonella Typhi O9 lipopolysaccharide in sera.
Methods: We assessed the sensitivity and specificity of the Tubex test among Tanzanian children hospitalized with
febrile illness using blood culture as gold standard. Evaluation was done considering blood culture confirmed S.
Typhi with non-typhi salmonella (NTS) and non - salmonella isolates as controls as well as with non-salmonella
isolates only.
Results: Of 139 samples tested with Tubex, 33 were positive for S. Typhi in blood culture, 49 were culture-
confirmed NTS infections, and 57 were other non-salmonella infections. Thirteen hemolyzed samples were
excluded. Using all non - S. Typhi isolates as controls, we showed a sensitivity of 79% and a specificity of 89%.
When the analysis was repeated excluding NTS from the pool of controls we showed a sensitivity of 79% and a
specificity of 97%. There was no significant difference in the test performance using the two different control
groups (p > 0.05).
Conclusion: This first evaluation of the Tubex test in an African setting showed a similar performance to those
seen in some Asian settings. Comparison with the earlier results of a Widal test using the same samples showed
no significant difference (p > 0.05) for any of the performance indicators, irrespective of the applied control group.
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Background
Typhoid fever remains a significant health problem in
many developing countries. Estimates suggest an incidence
rate of more than 21.5 million cases globally in the year
2000 [1]. Recent data from Tanzania mainland have found
a strong variation of prevalence rates among blood culture
positive isolates collected in local hospitals, ranging from
9% [2] to 21.4% [3] for Salmonella enterica serovar Typhi
(S. Typhi), no data from Zanzibar are available to date. As
the clinical picture of typhoid fever is often unspecific,
misdiagnosis and insufficient or inadequate treatment are
potential risks associated with the disease. In the absence
of difficult-to-obtain bone marrow specimens, microbiolo-
gic culture of a blood sample is considered to be the cur-
rent state-of-the art test for the diagnosis of typhoid fever
even though its sensitivity may be as low as 40% [4,5]. Cul-
ture may take up to seven days and requires a well-run
and equipped laboratory, which is often not available in
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settings with endemic typhoid fever. The widely in use
Widal test provides a cost efficient alternative [6] for sero-
logical diagnosis, however its performance remains unsa-
tisfying with sensitivity reported from Tanzania of 75%
using blood culture as the gold standard and applying a
cut off titer of 1:80 [7]. The test further requires the estab-
lishment of a local cut off titer prior to use which is com-
plicated. Therefore, a rapid test with a performance
comparable to that of blood culture would be desirable.
A rapid diagnostic test for typhoid fever, Tubex® is
commercially available that uses particle separation to
detect immunoglobulin M (IgM) directed towards Sal-
monella enterica serovar Typhi (S. Typhi) O9 lipopoly-
saccharide in patient sera. Performance of the test has
previously been evaluated in a number of studies in Asia
but none in Africa. Using blood culture results for com-
parison, we assessed the sensitivity and specificity of the
Tubex test among Tanzanian children hospitalized with
febrile illness and compared our results with those from
previous studies.
Methods
For evaluation of the Tubex test, we used a selected
subset of serum samples that was obtained for a fever
surveillance study [2] from Teule Hospital in Muheza
District, Tanzania. In order to accommodate the
required sample size for the test validation, we included
randomly selected and age-matched Salmonella enterica
serotype Typhi (S. Typhi) positive serum samples from a
second fever surveillance study conducted at Chake
Chake Hospital in Pemba, Zanzibar. All samples were
collected from children between the ages of 2 months to
14 years from 2008 to 2009.
At Teule Hospital in Muheza, sera and blood was col-
lected for culture from children with a history of three
days of fever, or a history of less than three days of
fever but with at least one of the following severity cri-
teria: respiratory distress; deep breathing; respiratory
distress in combination with severe pallor; prostration;
capillary refill ≥3 seconds; temperature gradient; systolic
blood pressure <70 mm Hg; coma defined by Glasgow
Coma Scale (GCS) ≤ 10 or Blantyre Coma Scale (BCS)
≤ 2; severe jaundice; history of two or more convulsions
in the last 24 hours; blood glucose <3 mmol associated
with clinical signs; neck stiffness; bulging fontanel; or
oxygen saturation <90% [2].
At Chake Chake Hospital in Pemba, sera and blood
was collected for culture from children with a recorded
body temperature of >37.5°C for outpatients and any
history of fever for inpatients. Duration of fever was not
considered for study recruitment.
About 3 to 5 milliliters (ml) of blood (depending on
body weight) was collected and inoculated in a BactA-
LERT™ Pediatric-fan bottle (Teule Hospital) or a
BacTec Peds PLUS ™/F bottle (Chake Chake Hospital)
and incubated in the respective machine (BacT/ALERT
3D or BacTec 9050). Bacterial growth was evaluated fol-
lowing standard procedures.
The Tubex® test (IDL - Sweden) was conducted
according to the manufacturer’s instructions, which are
as follows. Forty-five microliters (μl) of antigen covered
particles were added to the Tubex Reaction Well Strip
and 45 μl of non-hemolyzed serum was added. After
two minutes of incubation time, 90 μl of magnetic anti-
body coated solution was added, and the strip was
sealed and shaken for two minutes. The strip was then
placed on a magnetic tray for five minutes, separating
the particles if a positive sample had been added. The
resulting color change of the solution was read and
categorized on a scale from 0 to 10. The results were
interpreted as positive for scores of 4 or greater and as
negative for scores of 2 or below as per the manufac-
turer’s instructions. Samples with a color corresponding
to the value of 3 were interpreted as indeterminate. All
blood culture isolates from individuals that matched the
inclusion criteria and that were not considered a con-
taminant were included in the analysis.
We performed the Tubex test on non-hemolyzed
serum samples from the patients of the two surveillance
studies who had blood culture-confirmed S. Typhi
(defined as group 1), randomly selected cases of non-
Typhi serotypes of S. enterica (NTS) (defined as group
2), and randomly selected cases with other (non-Salmo-
nellae) pathogenic bacteria (defined as group 3). Staff
members performing the Tubex test were blinded to the
blood culture results.
For the analysis, sensitivity (true-positive rate) was
defined as the probability that the Tubex test result will
be positive when there is blood culture-confirmed
typhoid fever (group 1) and specificity (true-negative
rate) was defined as the probability that the Tubex® test
result will be negative when S. Typhi is not isolated
from blood culture (groups 2 and 3). We conducted a
secondary analysis using only group 3 as the control
group. Comparison of test performance using different
control groups was done using the Yates Chi-Square
Test corrected for continuity.
We conducted a literature review in order to compare
our findings with those from previous studies. We
included studies of the Tubex test, which were identified
by directly searching the MEDLINE database through
PubMed. All articles since the first publication of the
test [8] were included. We also conducted a supplemen-
tary search of references in retrieved articles. Abstracts
were reviewed, and if relevant, the article was included.
A comparison of performance of the Tubex® test with
earlier published Widal test results obtained from the
same samples was done using McNemar’s Test for
Ley et al. BMC Infectious Diseases 2011, 11:147
http://www.biomedcentral.com/1471-2334/11/147
Page 2 of 6
Correlated Proportions http://faculty.vassar.edu/lowry/
VassarStats.html.
The fever surveillance studies at Chake-Chake and
Teule Hospitals were approved by their respective local
ethical review boards (Tanzania and Zanzibar), as well
as by the International Vaccine Institute’s Institutional
Review Board. Written informed consent was obtained
from legal guardians of all participants prior to any sam-
ple or data collection.
Results
A total of 139 samples were tested with Tubex. Thirty-
three were found positive for S. Typhi in blood culture
(group 1), 49 were culture-confirmed non-S. Typhi
(NTS) infection (group 2), and 57 were other non-Salmo-
nella infections that were not contaminants (group 3).
Thirteen hemolyzed samples were excluded (Figure 1).
Of the 33 blood culture-positive S. Typhi cases, 26
had a positive Tubex result and were considered as true
positives. Of the 106 blood culture confirmed NTS and
non-salmonella cases (groups 2 and 3), 94 yielded a
negative Tubex result and were considered as true nega-
tives. Considering only the 57 non-Salmonella cases
(group 3) as controls, resulted in 54 true negative cases.
Using groups 2 and 3 as controls showed a sensitivity
of 79% and a specificity of 89% (Table 1). The same
analysis was repeated excluding NTS from the pool of
controls and showed 79% and 97% for sensitivity and
specificity, respectively. There was no significant differ-
ence in the test performance using the two different
control groups (all were p > 0.05 using the Chi square
test).
A total of 14 articles were retrieved and evaluated for
inclusion into the review. All of the reported studies
were performed in Asia; none in Africa. A total of six
articles were excluded: two evaluated the test for non-
typhoidal Salmonella [9] or S. Paratyphi [10], three did
not evaluate the sensitivity and specificity of the test
[11-13], and one was a letter to the editor [14]. Thus,
eight publications were included in the review (Table 2).
 
 
 
 
 
 
 
 
*Age-matched, randomly selected 
**Randomly selected 
*** 17 from Zanzibar and 16 from Teule  
+ Other bacterial growth included: 11x Escherichia coli, 10x Haemophilus influenzae type B, 8x Streptococcus pneumoniae, 6x Pseudomonas
spp., 5x Acinetobacter baumannii, 3x Streptococcus beta – hemolytic group A, 3x Haemophilus influenzae, 2x Staphylcoccus aureus, 1x
Burkholderia cepacia, 1x Streptococcus beta-hemolytic group C , 1x Campylobacter spp., 1x Pateurella multocida, 1x gram negative rods
(not identified further), 1x Citrobacter braakii, 1x Stenotrophomonas, 1x Haemophilus parainfluenzae, 1x Streptococcus beta - hemolytic 
189 serum samples with positive blood culture results from Teule 
13 excluded (hemolyzed) 
33 S. Typhi*** 
=> group 1 
57 other bacterial 
growth included** 
=> group 3 
49 Nontyphi  
=> group 2 
54  other bacterial 
growth excluded** 
17 serum samples with positive 
blood culture results for 
Salmonella Typhi from Pemba, 
Zanzibar* 
Figure 1 Specimen assembly.
Table 1 Performance of Tubex® using group 1 as true
positives and two different control groups as true
negatives
Control Group
Group 2 + 3* Group 3*
Sensitivity (95% CI) 0.79 (0.52-0.81) 0.79 (0.62-0.90)
(absolute numbers) (26/33) (26/33)
Specificity (95% CI) 0.89 (0.81-0.94) 0.97 (0.85-0.99)
(absolute numbers) (94/106) (94/97)
*Group 1 = S. Typhi (n = 33), Group 2 = all non-yphi Salmonella (n = 49),
Group 3 = all blood culture-positive non-Salmonella cases (n = 57).
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Five of the included articles reported findings of test
performance that were similar to our results [15-19].
Two publications showed considerably lower sensitivity
and specificity [20,6], and one reported higher values [8]
(Table 2).
Discussion
We found Tubex has a sensitivity of 79% using either
control group (95%CI: 52-81% for groups 2 and 3, and
62-90% for group 3 only) and a specificity of 89-97%
(95%CI: 81-94% for groups 2 and 3 and 85-99% for
Table 2 Comparison of the performance of the Tubex® test from published reports
Author Year Journal Sample
Size
Location Tubex®
cut off
Sens Spec True neg.
definition
Reader Gold
standard
Study
population
Ley, B. et
al
This
paper
This
Journal
139 Tanzania >4 79% 89% All non-typhi
bacteriamia
Investigator Blood Culture
(BACTEC)
>2 months +
>37.5°
(inpatients) &
history of
fever
(outpatients)
88 79% 97% All non-
salmonella
bacteriamia
Naheed,
A. et al
2008 Diagn
Microbiol
Infect Dis.
867 Bangladesh ≥4 60% 58% Other confirmed
bacteremia
ICDDRB lab Manual Blood
Culture
Active
surveillance
Temp ≥38°C
60% 64% Blood culture neg
& other
bacteremia
Rahman,
M. et al
2007 Diagn
Microbiol
Infect Dis.
243 Bangladesh >4 91.2% 82.3% Other febrile
patients
ICDDRB lab,
min. 2
independent
lab techs
Manual Blood
Culture
Outpatients,
all ages with
history of
fever
No.
Pos
89.5% Healthy subjects Healthy
subjects
Dong, B.
et al
2007 Epidemiol.
Infect.
1732 China ≥2 100% 43% Paratyphoid cases - Blood culture
(BACTEC)
Age 5-60
with reported
history of
fever for 3
days
≥4 69% 95%
≥6 62% 95%
≥8 23% 100%
≥10 15% 100%
Kawano,
R. L. et al
2006 JCM. 177 Philippines ≥2 94.7% 80.4% Blood culture
neg.
n/A Manual Blood
Culture
&BACTEC
Clinically
suspected
typhoid cases
Dutta, S.
et al
2006 Diagn
Microbiol
Infect Dis.
495 India ≥4 56% 88% Paratyphoid and
malaria cases
n/A Blood Culture
BACTEC
Outpatients,
all ages, Pat
with history
of fever for 3
days
Ohlsen,
S. J. et al
2004 JCM. 79 Vietnam According
to
protocol
78% 94% Other lab-
confirmed febrile
illnesses
n/A Manual Blood
Culture/
BACTEC
Pat ≥3 year
and history of
≥4 day fever
House,
D. et al
2001 JCM. 127 Vietnam >2 87% 76% Febrile
hospitalized
patients
labtech Culture Children and
adults
Lim et al 1998 JCM. 105 Hong
Kong &
Malaysia
>2 100% 100% Healthy
individuals and
pat with other
bacterial diseases
and autoimmune
disease
labtechs Culture
confirmed
(56% of pos.),
clinical picture,
various other
tests
Clinical
picture,
culture
confirmed,
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group 3 only) irrespective of control group. To our
knowledge, this is the first evaluation of the test in an
African population. Our results were similar to those
observed in previous studies (five out of eight studies) in
Asia assessing the performance of the test [15-19],
though Kawano et al. [17] and House et al. [19] used a
lower cut-off titer than is recommended in the manual.
In contrast, two studies [20,6] found the performance of
Tubex to be poorer than our findings, despite using a
similar cut-off value, gold standard, and inclusion cri-
teria. The extremely good performance of Tubex
observed by Lim et al. [8] has not been reproduced
since.
An important limitation of this study is that the sera
are combined from two different patient populations
and the purposeful selection of samples included in the
three groups. During the preparation of the study, we
calculated the sample sizes of true positive sera and true
negative sera that are required for validation of the
Tubex test and for comparison with the Widal test per-
formance. The number of true positive sera from either
hospital alone was insufficient for the validation. Thus,
we included S. Typhi blood culture-confirmed sera from
Pemba. Analysis of the results by hospital was not possi-
ble because of insufficient sample size.
In a sub-analysis in assessing cross reactivity with
NTS, blood culture-confirmed NTS cases were consid-
ered as true positives, and all other positive isolates,
excluding S. Typhi, were considered as true negatives. In
this sub-analysis Tubex had a sensitivity of 18% and a
specificity of 95% (analysis not shown).
Comparison with a Widal test that was earlier con-
ducted using the same samples [7] revealed no signifi-
cant difference (p > 0.05) for any of the performance
indicators, irrespective of the applied control group. But
compared to the Widal test, Tubex is easier and quicker
to perform. The Widal test requires 16 - 20 hours until
the results are obtained while the complete procedure
for the Tubex test is approximately 20 minutes. Tubex
is more expensive at approximately 2.15 USD per test
compared to <0.80 USD per test for the Widal tube
agglutination test [6].
Interpreting the Tubex test results was found to be
difficult and the results were prone to inter - reader var-
iation. Assessing the color change according to the pro-
vided color scale requires experience and standardized
good lighting conditions. The Tubex test can only be
applied to non-hemolyzed and non-icteric serum sam-
ples, thus limiting its general application. However Tam
et al. [12] have described a method that includes a
washing step and thereby addresses the problem of tur-
bid serum. This method requires double the amount of
antigen-coated particles as well as glycine buffered saline
(GBS), thereby increasing the price per sample to
approximately 4.50 USD and reducing its feasibility as
an easy-to-perform test. While neither of the tests can
be performed by untrained staff, interpretation of results
is considered easier for the Widal test compared to
Tubex.
Conclusion
The advantages of Tubex over the Widal test and the
gold standard of blood culture is the short time it
requires to obtain a result, and it does not require estab-
lishing a local cut-off value as with the Widal. In set-
tings that can afford the relatively high cost of Tubex
and that require instant individual diagnoses to support
the clinical diagnosis of typhoid fever, Tubex is superior
to the Widal tube agglutination test. For screening and
surveillance purposes, as well as in settings with limited
financial and technical resources, the Widal tube agglu-
tination test is a possible alternative that can provide a
similar performance as Tubex at a lower cost though it
requires more time. Our evaluation of Tubex showed
that any result must be handled with precaution. Results
should be considered as indicative, not confirmatory.
The test may be used to exclude disease though. In con-
clusion, the need for a reliable, fast, cheap, and easy-to-
apply rapid diagnostic test for typhoid fever remains in
high demand.
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